全文获取类型
收费全文 | 1645篇 |
免费 | 62篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 26篇 |
妇产科学 | 95篇 |
基础医学 | 191篇 |
口腔科学 | 15篇 |
临床医学 | 95篇 |
内科学 | 540篇 |
皮肤病学 | 14篇 |
神经病学 | 95篇 |
特种医学 | 87篇 |
外科学 | 137篇 |
综合类 | 11篇 |
预防医学 | 61篇 |
眼科学 | 21篇 |
药学 | 141篇 |
肿瘤学 | 174篇 |
出版年
2023年 | 4篇 |
2022年 | 58篇 |
2021年 | 119篇 |
2020年 | 32篇 |
2019年 | 43篇 |
2018年 | 61篇 |
2017年 | 48篇 |
2016年 | 42篇 |
2015年 | 45篇 |
2014年 | 44篇 |
2013年 | 91篇 |
2012年 | 133篇 |
2011年 | 127篇 |
2010年 | 70篇 |
2009年 | 58篇 |
2008年 | 108篇 |
2007年 | 106篇 |
2006年 | 105篇 |
2005年 | 100篇 |
2004年 | 87篇 |
2003年 | 95篇 |
2002年 | 65篇 |
2001年 | 14篇 |
2000年 | 8篇 |
1999年 | 7篇 |
1998年 | 14篇 |
1997年 | 5篇 |
1996年 | 5篇 |
1995年 | 3篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 6篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1980年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有1718条查询结果,搜索用时 15 毫秒
1.
2.
Während konventionelle zytotoxische
Agenzien unspezifisch sind und nicht zwischen Tumorzelle und
gesunder Wirtszelle unterscheiden, soll der gezielte
therapeutische Eingriff in veränderte Signalkaskaden der
Tumorzellen wirksame und gleichzeitig nebenwirkungsärmere
Therapiemöglichkeiten eröffnen. 相似文献
3.
Kowalczyk JR Gaworczyk A Winnicka D Lejman M Babicz M 《Cancer Genetics and Cytogenetics》2003,142(1):51-55
Fluorescence in situ hybridization (FISH) using chromosome-specific DNA probes is rapidly becoming a part of clinical laboratory practice. However, as a relatively new clinical test, it is not yet standardized and for practical reasons each laboratory must establish its own criteria. For this purpose we have evaluated the specificity of a dual-color BCR/ABL translocation probe by establishing the range of BCR/ABL fusion-positive scores in a healthy donor group. The false positive rate (FPR), determined by the percent of FISH BCR/ABL fusion-positive cells found in the specimens of healthy donors, was estimated at 2.3% (mean = 1%-4%). Thus the cut-off value for false positive nuclei was set at 5%. 相似文献
4.
Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships 总被引:9,自引:0,他引:9
This review focuses on recent advances in the structure-function relationships of thyroid-stimulating hormone (TSH) and its receptor. TSH is a member of the glycoprotein hormone family constituting a subset of the cystine-knot growth factor superfamily. TSH is produced by the pituitary thyrotrophs and released to the circulation in a pulsatile manner. It stimulates thyroid functions using specific membrane TSH receptor (TSHR) that belongs to the superfamily of G protein-coupled receptors (GPCRs). New insights into the structure-function relationships of TSH permitted better understanding of the role of specific protein and carbohydrate domains in the synthesis, bioactivity, and clearance of this hormone. Recent progress in studies on TSHR as well as studies on the other GPCRs provided new clues regarding the molecular mechanisms of receptor activation. Such advances are a result of extensive site-directed mutagenesis, peptide and antibody approaches, detailed sequence analyses, and molecular modeling as well as studies on naturally occurring gain- and loss-of-function mutations. This review integrates expanding information on TSH and TSHR structure-function relationships and summarizes current concepts on ligand-dependent and -independent TSHR activation. Special emphasis has been placed on TSH domains involved in receptor recognition, constitutive activity of TSHR, new insights into the evolution of TSH bioactivity, and the development of high-affinity TSH analogs. Such structural, physiological, pathophysiological, evolutionary, and therapeutic implications of TSH-TSHR structure-function studies are frequently discussed in relation to concomitant progress made in studies on gonadotropins and their receptors. 相似文献
5.
Sowiska-Klencka D Klencki M Dedecjus M Lewiski A Pawlikowski M 《Endocrine pathology》2000,11(2):173-178
Nucleolar organizer regions (NORs) are segments of DNA, encoding for ribosomal RNA. They are associated with argyrophilic
proteins and, thus, they can be localized through silver staining. A correlation has been shown between the number, the size,
or the intranuclear localization of AgNORs, and the proliferative activity of cells. The aim of this study was to examine
numerous features of AgNORs in pituitary adenomas and to relate them to immunohistochemical typing of tumor. Histologic slides
from 32 pituitary tumors and one normal pituitary were silver-stained and analyzed with a computerized system for microscopic
image analysis, supported by an AgNORmeter95 program. All the tumors were also immunocyto chemically characterized. We have
found that gonadotropinomas, when compared with plurihormonal adenomas, revealed a lower proportion of nuclei with a single
AgNOR and a higher percentage of marginal dots. Recurrent adenomas, when compared with primary adenomas, showed a higher proportion
of nuclei with three AgNOR dots, a larger total area of dots in the nuclei, and a higher standard deviation of the AgNOR dot
area in the nucleus. Adenomas immunopositive for prolactin, when compared with immunonegative ones, showed a larger mean area
of the AgNOR dot, a larger area of the biggest dot in the nucleus, and a higher proportion of nuclei within a single dot.
These results suggest that the estimated parameters of AgNOR dots differ according to tumor aggressiveness and to the hormone
immunopositivity of pituitary adenomas. 相似文献
6.
Mariusz Papp Piotr Gruca Pierre-Alain Boyer Elisabeth Moca?r 《Neuropsychopharmacology》2003,28(4):694-703
Chronic mild stress (CMS), a well-validated model of depression, was used to study the effects of the melatonin agonist and selective 5-HT(2C) antagonist agomelatine (S 20098) in comparison with melatonin, imipramine, and fluoxetine. All drugs were administered either 2 h before (evening treatment) or 2 h after (morning treatment) the dark phase of the 12-h light/dark cycle. Chronic (5 weeks) evening treatment with agomelatine or melatonin (both at 10 and 50 mg/kg i.p.) dose-dependently reversed the CMS-induced reduction in sucrose consumption. The magnitude and time course of the action of both drugs was comparable to that of imipramine and fluoxetine (both at 10 mg/kg i.p.); however, melatonin was less active than agomelatine at this dose. The effect of evening administration of agomelatine and melatonin was completely inhibited by an acute injection of the MT(1)/MT(2) antagonist, S 22153 (20 mg/kg i.p.), while the antagonist had no effect in animals receiving fluoxetine or imipramine. When the drugs were administered in the morning, agomelatine caused effects similar to those observed after evening treatment (with onset of action faster than imipramine) but melatonin was ineffective. Moreover, melatonin antagonist, S 22153, did not modify the intakes in stressed animals receiving morning administration of agomelatine and in any other control and stressed groups tested in this study. These data demonstrate antidepressant-like activity of agomelatine in the rat CMS model of depression, which was independent of the time of drug administration. The efficacy of agomelatine is comparable to that of imipramine and fluoxetine, but greater than that of melatonin, which had no antidepressant-like activity after morning administration. While the evening efficacy of agomelatine can be related to its melatonin receptors agonistic properties, its morning activity, which was not inhibited by a melatonin antagonist, indicates that these receptors are certainly required, but not sufficient to sustain the agomelatine efficacy. It is therefore suggested that the antidepressant-like activity of agomelatine depends on some combination of its melatonin agonist and 5-HT(2C) antagonist properties. 相似文献
7.
Alessio Nencioni Lucia Wille Giovanna Dal Bello Davide Boy Gabriella Cirmena Sebastian Wesselborg Claus Belka Peter Brossart Franco Patrone Alberto Ballestrero 《Clinical cancer research》2005,11(11):4259-4265
PURPOSE: Bcl-2 overexpression is frequently detected in lymphoid malignancies, being associated with poor prognosis and reduced response to therapy. Here, we evaluated whether Bcl-2 overexpression affects the cytotoxic activity of proteasome inhibitors taken alone or in association with conventional anticancer drugs or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). EXPERIMENTAL DESIGN: Jurkat cells engineered to overexpress Bcl-2 were treated with proteasome inhibitors (MG132, epoxomicin, and bortezomib), anticancer drugs (etoposide and doxorubicin), TRAIL, or combinations of these compounds. Cell death and loss of mitochondrial transmembrane potential were detected by flow cytometry. Cytosolic relocalization of cytochrome c and SMAC/Diablo, caspase cleavage, and Bcl-2 and Mcl-1 levels were determined by immunoblotting. Nuclear factor-kappaB inhibition was done by retroviral transduction with a dominant-negative mutant of IkappaBalpha. RESULTS: Bcl-2 overexpression results in significant inhibition of apoptosis in response to proteasome inhibitors, antiblastics, and TRAIL. Addition of TRAIL to proteasome inhibitors results in a synergistic cytotoxic effect in Bcl-2-overexpressing cells, whereas this result is not reproduced by the combination of proteasome inhibitors with antiblastic drugs. Importantly, proteasome inhibitors plus TRAIL induce mitochondrial dysfunction irrespective of up-regulated Bcl-2. Bcl-2 cleavage to a fragment with putative proapoptotic activity and elimination of antiapoptotic Mcl-1 may both play a role in proteasome inhibitors-TRAIL cooperation. Conversely, nuclear factor-kappaB inhibition by proteasome inhibitors is per se insufficient to explain the observed synergy. CONCLUSIONS: Combined proteasome inhibitors and TRAIL overcome the apoptotic threshold raised by Bcl-2 and may prove useful in the treatment of chemoresistant malignancies with up-regulated Bcl-2. 相似文献
8.
S. Magnitsky G. K. Belka C. Sterner S. Pickup L. A. Chodosh J. D. Glickson 《NMR in biomedicine》2013,26(1):35-42
This study compared the steady state concentration of lactate in an inducible Her2/nue transgenic breast cancer mouse model and in tumours from the same Her2/neu model grown orthotopically. In vivo lactate was detected by MRS using the Hadamard encoded selective multiple quantum coherence pulse sequence (HadSelMQC) recently developed by our laboratory. A lower lactate signal was observed in the inducible tumours compared to orthotopic tumours in vivo, while ex vivo analysis of perchloric acid extracts revealed similar amounts of this metabolite in both models. Histological staining of mammary tumour specimens showed a much higher level of fat tissue in inducible tumours compared to the orthotopic model. Phantom studies with [3‐13C] lactate indicated that a lipid environment could significantly reduce the T2 of lactate and impede its detection. The transgenic inducible model for breast cancer not only better recapitulated the biological aspects of the human disease but also provided additional characteristics related to in vivo detection of lactate that are not available in orthotopic or xenograft models. This study suggests that the level of lactate measured by the HadSelMQC pulse sequence may be underestimated in human patients in the presence of high lipid levels that are typically encountered in the breast. Copyright © 2012 John Wiley & Sons, Ltd. 相似文献
9.
10.